New Zealand markets open in 3 hours 46 minutes

Clinuvel Pharmaceuticals Limited (CUV.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
15.29+0.14 (+0.92%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
81,223
78,321
65,722
47,976
32,565
Cost of revenue
9,630
8,790
10,484
4,720
9,630
Gross profit
73,319
69,532
55,238
43,255
22,936
Operating expenses
Selling general and administrative
26,331
22,567
17,712
12,760
1,889
Total operating expenses
30,111
25,429
19,908
15,031
11,545
Operating income or loss
43,208
44,102
35,330
28,224
11,390
Interest expense
25.886
3,193
2,274
1,618
25.886
Total other income/expenses net
288.537
763.082
821.152
-1,236
781.319
Income before tax
45,784
45,579
34,321
25,713
13,136
Income tax expense
15,632
14,974
13,442
984.397
-3,510
Income from continuing operations
30,153
30,605
20,878
24,728
16,647
Net income
30,153
30,605
20,878
24,728
16,647
Net income available to common shareholders
30,153
30,605
20,878
24,728
16,647
Basic EPS
0.49
0.62
0.42
0.50
0.34
Diluted EPS
0.47
0.59
0.40
0.48
0.33
Basic average shares
49,796
49,410
49,410
49,410
49,260
Diluted average shares
51,298
51,784
51,808
51,091
50,445